<DOC>
	<DOCNO>NCT00898053</DOCNO>
	<brief_summary>This laboratory study look tumor sample patient Ewing sarcoma . Studying sample tumor tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer</brief_summary>
	<brief_title>Study Tumor Samples From Patients With Ewing Sarcoma</brief_title>
	<detailed_description>Study Subtype : Ancillary/Correlative Observational Study Model : Cohort Time Perspective : Prospective Biospecimen Retention : Samples With DNA Biospecimen Description : Tissue Study Population Description : Samples collect AEWS0031 patient register AEWS08B1 Sampling Method : Non-Probability Sample PRIMARY OBJECTIVES : I . Determine mutation p53 , and/or deletion p16 locus , prognostic value patient Ewing sarcoma . SECONDARY OBJECTIVES : I . Estimate incidence p53 mutation Ewing sarcoma sample collect COG study . II . Estimate incidence p16 deletion Ewing sarcoma sample collect COG study . III . Prepare archive amplify genomic DNA Ewing sarcoma sample collect COG study future biologic analysis . OUTLINE : This multicenter study . Previously archive tumor sample analyze p53 mutation p16 deletion immunohistochemistry , FISH , PCR , DNA sequencing .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Neuroectodermal Tumors</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive , Peripheral</mesh_term>
	<criteria>Diagnosis Ewing sarcoma Banked specimens patient enrol AEWS0031</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>